Visiongain Publishes Aflatoxicosis Treatment Market Report to 2031

11 March 2021
Pharma

Visiongain has published a new report on Aflatoxicosis Treatment Market Report to 2031: Forecasts by Treatment (Blood Transfusion, Oxygen Therapy, Antibiotics, Antihistamines, Immunosuppressant, and Others) PLUS COVID-19 Recovery Scenarios.

Global Aflatoxicosis Treatment market size is projected to reach US$ XX Million in 2021 and is expected to display strong revenue growth through to 2031.

COVID-19 Impact on Aflatoxicosis Treatment Market
The COVID-19 pandemic has deleteriously affected all the countries and industries. Similarly, the aflatoxicosis treatment market is anticipated to take a hit. The target industry is now facing challenges to manage the interrupted demand and supply of components. Also, unpredictable and disturbing supply chain activities and the unavailability of human resources are anticipated to impact the target industry growth. Hence, the overall COVID-19 impact is expected to continue to moderate for the global key players operating in the industry.

Market Drivers

Increasing Instances of Foodborne Illness
Aflatoxins are toxic substances produced by a few types of fungi that are found naturally across the world; they can pollute food crops and stance a severe health risk to people and livestock. According to the World Health Organization (WHO), aflatoxins pose an important economic burden, triggering an estimated to be around 25% or more of the world’s food yields to be ruined annually.

Growing Awareness and Rising Spending in the Research & Development
The key factors pushing the growth of the aflatoxicosis treatment market are the prevalence of aflatoxicosis disease around the world. Besides, increased disposable income in developing countries such as India and China and rising healthcare spending are also accelerating the growth of the aflatoxicosis treatment market. Moreover, rising awareness among the population and the development of healthcare infrastructure are contributing to the target industry growth. Therefore, the rising research & development activities to develop ground-breaking and effective treatments for aflatoxicosis is fueling the target industry growth.

Market Opportunities

Expansion Opportunities in Emerging Markets
The rising food trade across the boundaries of developing markets rises the opportunity for global aflatoxicosis treatment. The growing occurrences of food-borne diseases and inappropriate hygiene & processing circumstances in the factories. Moreover, growing cases of mycotoxin outbreaks from developing countries such as Asia and Africa are likely to create lucrative opportunities for the target industry growth. These countries are frequently exposed to high levels of aflatoxins, which leads to immunotoxicity, carcinogenicity, and growth retardation in animals.

Competitive Landscape
Key players operating in the global Aflatoxicosis Treatment market are Pfizer Inc., Zydus Cadilla, Glaxo Smith Kline, Sanofi, Johnson and Johnson, Abbott Laboratories, and many others.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Clinical Trial Supplies Market Report 2021-2031

Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.

11 October 2021

Read

Visiongain Publishes Drug Discovery Informatics Market Report 2021-2031

High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.

07 October 2021

Read

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2021-2031

Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.

06 October 2021

Read

Visiongain Publishes Meningococcal Vaccines Market Report 2021-2031

Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is expected to drive the global meningococcal vaccines market

05 October 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever